Evaluating the evidence for the implementation of c-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: A systematic review

Family Practice

Volumn 29, Issue 4, 2012, Pages 383-393

  Engel, Madelon F ^a   Paling, F P ^a   Hoepelman, A I M ^a   van der Meer, V ^b   Oosterheert, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aetiology; Antibiotic prescription; C reactive protein; Diagnosis; Point of care; Primary care; Prognosis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ANTIBIOTIC THERAPY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE COURSE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MEDICAL DECISION MAKING; MORTALITY; PNEUMONIA; POINT OF CARE TESTING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT PLANNING;

ADULT; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; INAPPROPRIATE PRESCRIBING; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; POINT-OF-CARE SYSTEMS; PRIMARY HEALTH CARE; PROGNOSIS;

EID: 84864928665     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmr119     Document Type: Review

References (36)

1. Hopstaken RM, Butler CC, Muris JW et al. Do clinical findings in lower respiratory tract infection help general practitioners prescribe antibiotics appropriately? An observational cohort study in general practice. Fam Pract 2006; 23: 180-7.
2. Jakobsen KA, Melbye H, Kelly MJ et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care 2010; 28: 229-36.
3. European antimicrobial resistance surveillance system (EARSS). The microbial threat. 2005. http://www.rivm.nl/earss/Background/ (accessed on June 2011).
4. Cals JW, Schot MJ, de Jong SA, Dinant GJ, Hopstaken RM. Pointof-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med 2010; 8: 124-33.
5. Llor C, Sierra N, Hernandez S et al. Impact of C-reactive protein testing on adherence to thrice-daily antibiotic regimens in patients with lower respiratory tract infection. Prim Care Respir J 2010; 19: 358-62.
6. Afinion CRP, Product Documentation Summary. Oslo, Norway: Axis-Shield. www.afinion.net and www.clindia.nl (accessed on August 2011).
7. Quickread Go CRP, Test before Prescribing. Espoo, Finland: Orion Diagnostica. www.oriondiagnostica.com and www. mediphos.com (accessed on 08 August 2011).
8. Product information Eurolyser Smart CRP rapid test, through importer and manufacturer. www.eurolyser.com and www. zkopehealthcare.com (accessed on 08 August 2011).
9. Verheij TJM, Hopstaken RM, Prins JM et al. The practice guideline 'Acute cough' from the Dutch College of General Practitioners. 2011. http://nhg.artsennet.nl/kenniscentrum/k_richtlijnen/k_nhgstandaarden/Samenvattingskaartje-NHGStandaard/M78_svk.htm (accessed on 1 December 2011).
10. van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ 2005; 331: 26.
11. Andre M, Schwan A, Odenholt I. Swedish Study Group on Antibiotic Use. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned. Scand J Infect Dis 2004; 36: 192-7.
12. Engstrom S, Molstad S, Lindstrom K, Nilsson G, Borgquist L. Excessive use of rapid tests in respiratory tract infections in Swedish primary health care. Scand J Infect Dis 2004; 36: 213-8.
13. Poses RM, Cebul RD, Collins M, Fager SS. The importance of disease prevalence in transporting clinical prediction rules. The case of streptococcal pharyngitis. Ann Intern Med 1986; 105: 586-91.
14. Knottnerus JA, van Weel C, Muris JW. Evaluation of diagnostic procedures. BMJ 2002; 324: 477-80.
15. Macfarlane J, Holmes W, Gard P et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56: 109-14.
16. Lim WS, Baudouin SV, George RC et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 (suppl 3): iii1-55.
17. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (suppl 2): S27-72.
18. Linden MWvd, Westert GP, Bakker DHd, Schellevis FG. Tweede nationale studie naar ziekten en verrichtingen in de huisartspraktijk. Klachten en aandoeningen in debevolking en in de huisartspraktijk. Utrecht/Bilthoven, The Netherlands: NIVEL & RIVM, 2004.
19. Jokinen C, Heiskanen L, JuvonenH et al. Incidence of communityacquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137: 977-88.
20. Holm A, Nexoe J, Bistrup LA et al. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract 2007; 57: 547-54.
21. Hopstaken RM, Muris JW, Knottnerus JA et al. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003; 53: 358-64.
22. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
23. Offringa M, Assendelft WJJ, Scholten RJPM. Klinisch handelen gebaseerd op bewijsmateriaal. Inleiding in Evidence-Based Medicine.Houten, The Netherlands: Bohn Stafleu Van Loghum, 2008.
24. Holm A, Pedersen SS, Nexoe J et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007; 57: 555-60.
25. Hopstaken RM, Stobberingh EE, Knottnerus JA et al. Clinical items not helpful in differentiating viral from bacterial lower respiratory tract infections in general practice. J Clin Epidemiol 2005; 58: 175-83.
26. Hopstaken RM, Coenen S, Butler CC et al. Prognostic factors and clinical outcome in acute lower respiratory tract infections: a prospective study in general practice. Fam Pract 2006; 23: 512-9.
27. Hopstaken RM, Nelemans P, Stobberingh EE et al. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial. J Fam Pract 2002; 51: 329-36.
28. Kavanagh KE, O'Shea E, Halloran R, Cantillon P, Murphy AW. A pilot study of the use of near-patient C-reactive protein testing in the treatment of adult respiratory tract infections in one Irish general practice. BMC Fam Pract 2011; 12: 93.
29. Diederichsen HZ, SkamlingM, Diederichsen A et al. A randomized controlled trial of the use of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Prim Health Care 2001; 163: 3784-7.
30. Melbye H, Aaraas I, Fleten N, Kolstrup N, Mikalsen JI. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults. Tidsskr Nor Laegeforen 1995; 115: 1610-5.
31. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009; 338: b1374.
32. Graffelman AW, Knuistingh Neven A, le Cessie S et al. A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment. Br J Gen Pract 2004; 54: 20-4.
33. Seppa Y, Bloigu A, Honkanen PO, Miettinen L, Syrjala H. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med 2001; 161: 2709-13.
34. Melbye H, Straume B, Brox J. Laboratory tests for pneumonia in general practice: the diagnostic values depend on the duration of illness. Scand J Prim Health Care 1992; 10: 234-40.
35. Cals JW, Ament AJ, Hood K et al. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. J Eval Clin Pract 2010; 17: 1059-69.
36. Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care 2010; 14: 203.